Six Monthly Block Listing Review

RNS Number : 9444E

Xeros Technology Group plc

04 July 2023

BLOCK LISTING SIX MONTHLY RETURN

The Company gives below the information required by Schedule 6 of the AIM Rules for Companies in connection with the Xeros Technology Group plc Enterprise Management Incentive Scheme, the Xeros Technology Group plc unapproved share option scheme, and Unexercised Warrants currently in issue.

Date: 4 July 2023

Name of applicant:		Xeros Technology Group Plc ("Company")
Name of scheme:		Xeros Technology Group plc Enterprise Management Incentive Scheme ("EMI Scheme") & Xeros Technology Group plc unapproved share option scheme ("USOS") & Unexercised Warrants, pursuant to the Company's capital fundraise announced 30 September 2022 ("Warrants")
Period of return:	From:	1 January 2023	To:	1 July 2023
Balance of unallotted securities under scheme(s) from previous return:		EMI: 41,433 ordinary shares of 0.1p each USOS: 13,776 ordinary shares of 0.1p each Unallocated: 120,000 ordinary shares of 0.1p each Warrants: 30,020,815 ordinary shares of 0.1p each
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		EMI: nil ordinary shares of 0.1p each USOS: nil ordinary shares of 0.1p each Unallocated: nil ordinary shares of 0.1p each Warrants: nil ordinary shares of 0.1p each
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		EMI: nil ordinary shares of 0.1p each USOS: nil ordinary shares of 0.1p each Unallocated: nil ordinary shares of 0.1p each Warrants: 2,794 ordinary shares of 0.1p each
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		EMI: 41,433 ordinary shares of 0.1p each USOS: 13,776 ordinary shares of 0.1p each Unallocated: 120,000 ordinary shares of 0.1p Warrants: 30,018,021 ordinary shares of 0.1p each

Name of contact:	Alex Tristram, Company Secretary
Telephone number of contact:	0114 2699656

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRRIMTTMTMMBBJ